Manulife (Manufacturers Life Insurance)’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $471K | Buy |
273,986
+2,160
| +0.8% | +$3.72K | ﹤0.01% | 2205 |
|
|
2025
Q1 | $905K | Sell |
271,826
-7,801
| -3% | -$26K | ﹤0.01% | 1854 |
|
|
2024
Q4 | $2.07M | Sell |
279,627
-32,280
| -10% | -$239K | ﹤0.01% | 1543 |
|
|
2024
Q3 | $2.93M | Sell |
311,907
-23,606
| -7% | -$222K | ﹤0.01% | 1414 |
|
|
2024
Q2 | $2.69M | Sell |
335,513
-23,475
| -7% | -$188K | ﹤0.01% | 1406 |
|
|
2024
Q1 | $5.32M | Buy |
358,988
+94,017
| +35% | +$1.39M | ﹤0.01% | 1167 |
|
|
2023
Q4 | $2.15M | Buy |
264,971
+1,042
| +0.4% | +$8.47K | ﹤0.01% | 1448 |
|
|
2023
Q3 | $1.2M | Buy |
263,929
+43,077
| +20% | +$196K | ﹤0.01% | 1639 |
|
|
2023
Q2 | $1.55M | Buy |
220,852
+56,165
| +34% | +$395K | ﹤0.01% | 1483 |
|
|
2023
Q1 | $1.01M | Buy |
164,687
+1,440
| +0.9% | +$8.8K | ﹤0.01% | 1632 |
|
|
2022
Q4 | $1.03M | Buy |
163,247
+3,426
| +2% | +$21.6K | ﹤0.01% | 1594 |
|
|
2022
Q3 | $1.53M | Sell |
159,821
-1,379
| -0.9% | -$13.2K | ﹤0.01% | 1454 |
|
|
2022
Q2 | $1.76M | Buy |
161,200
+57,897
| +56% | +$634K | ﹤0.01% | 1445 |
|
|
2022
Q1 | $1.73M | Buy |
+103,303
| New | +$1.73M | ﹤0.01% | 1547 |
|
|
2020
Q2 | – | Sell |
-71,140
| Closed | -$2.13M | – | 2888 |
|
|
2020
Q1 | $2.13M | Buy |
71,140
+5,435
| +8% | +$163K | ﹤0.01% | 1290 |
|
|
2019
Q4 | $1.82M | Sell |
65,705
-2,158
| -3% | -$59.7K | ﹤0.01% | 1426 |
|
|
2019
Q3 | $1.22M | Sell |
67,863
-275
| -0.4% | -$4.95K | ﹤0.01% | 1557 |
|
|
2019
Q2 | $1.67M | Buy |
68,138
+1,517
| +2% | +$37.2K | ﹤0.01% | 1436 |
|
|
2019
Q1 | $633K | Buy |
66,621
+8,055
| +14% | +$76.5K | ﹤0.01% | 1951 |
|
|
2018
Q4 | $518K | Buy |
58,566
+6,440
| +12% | +$57K | ﹤0.01% | 1939 |
|
|
2018
Q3 | $586K | Sell |
52,126
-6,983
| -12% | -$78.5K | ﹤0.01% | 2167 |
|
|
2018
Q2 | $757K | Buy |
59,109
+6,449
| +12% | +$82.6K | ﹤0.01% | 2065 |
|
|
2018
Q1 | $890K | Buy |
52,660
+6,843
| +15% | +$116K | ﹤0.01% | 1924 |
|
|
2017
Q4 | $367K | Buy |
45,817
+5,110
| +13% | +$40.9K | ﹤0.01% | 2534 |
|
|
2017
Q3 | $316K | Sell |
40,707
-1,128
| -3% | -$8.76K | ﹤0.01% | 2612 |
|
|
2017
Q2 | $308K | Sell |
41,835
-3,031
| -7% | -$22.3K | ﹤0.01% | 2668 |
|
|
2017
Q1 | $334K | Buy |
44,866
+6,212
| +16% | +$46.2K | ﹤0.01% | 2469 |
|
|
2016
Q4 | $269K | Buy |
38,654
+3,954
| +11% | +$27.5K | ﹤0.01% | 2561 |
|
|
2016
Q3 | $286K | Buy |
34,700
+2,675
| +8% | +$22K | ﹤0.01% | 2486 |
|
|
2016
Q2 | $259K | Buy |
32,025
+1,487
| +5% | +$12K | ﹤0.01% | 2515 |
|
|
2016
Q1 | $147K | Buy |
30,538
+1,038
| +4% | +$5K | ﹤0.01% | 2825 |
|
|
2015
Q4 | $227 | Buy |
29,500
+962
| +3% | +$7 | ﹤0.01% | 2559 |
|
|
2015
Q3 | $165 | Buy |
28,538
+586
| +2% | +$3 | ﹤0.01% | 2801 |
|
|
2015
Q2 | $257 | Buy |
+27,952
| New | +$257 | ﹤0.01% | 2651 |
|